Physician

Max Logan Gratrix, M.D.

According to 2025 Medicare claims, Max Gratrix, M.D. (NPI: 1275737710) practices dermatology in the Carson City, NV market, with the plurality of this provider's patient population coming from Carson City, NV. This provider's primary affiliated billing organization is CLEMMENSEN, ADAMS, & TACK PSC (NPI: 1780852368; TIN: 88-0175775) and primary practice location at 89703-4634.

Gratrix's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,318 traditional Medicare patients, billed 10,048 HCPCS/CPT codes, and received $609,384 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 986 prescription claims across 454 beneficiaries totaling $348,302 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 35 records totaling $653. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $11,369 to $609,384. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,173 to $348,302. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	88	222	$11,369
2016	447	1,374	$74,789
2017	771	2,825	$155,237
2018	1,777	8,723	$509,039
2019	1,774	8,880	$603,829
2020	1,704	8,588	$563,836
2021	1,801	9,571	$587,123
2022	2,119	9,790	$601,899
2023	2,052	9,324	$659,485
2024	2,318	10,048	$609,384

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	30	56	$3,173
2016	54	102	$3,395
2017	127	240	$9,627
2018	329	656	$60,053
2019	325	656	$62,278
2020	354	777	$105,496
2021	320	733	$123,520
2022	351	741	$26,477
2023	427	891	$335,853
2024	454	986	$348,302

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	439	495	$64
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,407	1,781	$58
17000	Destruction of precancer skin growth, 1 growth	757	964	$36
88305	Pathology examination of tissue using a microscope, intermediate complexity	1,047	1,622	$28
17003	Destruction of precancer skin growth, 2-14 growths	562	2,502	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	13	364	$101,846
Clobetasol Propionate	Clobetasol Propionate	118	3,677	$5,018
Triamcinolone Acetonide	Triamcinolone Acetonide	235	7,844	$3,034
Fluorouracil	Fluorouracil	44	1,313	$2,727
Doxycycline Hyclate	Doxycycline Hyclate	62	2,760	$2,099

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	35	$653	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Max Logan Gratrix, M.D.?

Tedicare shows public-source Medicare data for Max Logan Gratrix, M.D. (NPI 1275737710), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Max Logan Gratrix, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Max Logan Gratrix, M.D.?

Max Logan Gratrix, M.D. is linked to CLEMMENSEN, ADAMS, & TACK PSC (billing NPI 1780852368) in the available physician profile data.

Does Max Logan Gratrix, M.D. have Open Payments data?

Max Logan Gratrix, M.D. has 35 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.